Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Prefilled syringes (PFSs) have gained market share ... levels of uptake currently seen in Western Europe. In influenza vaccination, PFSs may cost more per dose than multidose vials (MDVs), but ...

The review by the EMA follows the U.S. Food and Drug Administration's (FDA) acceptance on January 8, 2025, of the same prefilled syringe for consideration. The vaccine, which has been available in ...

SMi are pleased to present the 12 th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15 th and 16 th January 2020. As Europe’s leading Pre-Filled Syringes ...

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

Administer additional doses of Recombivax HB (to complete a vaccination series) in accordance with ACIP recommendations. Shake the single-dose vial or single-dose prefilled syringe well to obtain ...

Administer additional doses of Recombivax HB (to complete a vaccination series) in accordance with ACIP recommendations. Shake the single-dose vial or single-dose prefilled syringe well to obtain ...

South Korea Prefilled Syringes Market The South Korea prefilled syringes market is expected to grow at a CAGR of 4.32% from 2024 to 2032, d ...

2010 Expert Reviews Ltd. Cite this: Vaccine Presentation in the USA: Economics of Prefilled Syringes versus Multidose Vials for Influenza Vaccination - Medscape - Nov 01, 2010.